Epidemiological considerations in planning HIV preventive vaccine trials
AIDS
.
2001:15 Suppl 5:S49-57.
doi: 10.1097/00002030-200100005-00008.
Authors
J Esparza
1
,
D Burke
Affiliation
1
WHO-UNAIDS HIV Vaccine Initiative, Health Technology and Pharmaceuticals, World Health Organization, 1211 Geneva 27, Switzerland.
[email protected]
PMID:
11816175
DOI:
10.1097/00002030-200100005-00008
No abstract available
Publication types
Review
MeSH terms
AIDS Vaccines* / administration & dosage
Clinical Trials as Topic / methods*
Female
HIV Infections / epidemiology*
HIV Infections / prevention & control*
Humans
Male
Research Design
Substances
AIDS Vaccines